Related Experiment Video
Updated: Aug 9, 2026
09:07
An Orthotopic Model of Murine Bladder Cancer
Published on: February 6, 2011
[Postcystectomy radiotherapy in bladder cancer]
J Salina Ramos1, M de las Heras González, A Serna Berna
1Area Funcional de Oncología, Hospital Virgen de la Arrixaca, El Palmar, Murcia, España. radioterapia@arrixaca.huva.es
Archivos Espanoles De Urologia
|September 15, 1999
Summary
Postcystectomy radiotherapy is rarely studied due to low recurrence rates and high obstruction risks. This analysis examines tumors that could benefit from adjuvant radiotherapy, especially those with high local recurrence risks.
Area of Science:
- Oncology
- Radiation Oncology
Context:
- Postcystectomy radiotherapy is under-investigated.
- Previous studies focused on preoperative radiotherapy.
- High rates of intestinal obstruction are a concern.
Purpose:
- To analyze the potential benefits of adjuvant radiotherapy after cystectomy.
- To identify specific tumor types that could benefit from coadjuvant radiotherapy.
- To address the lack of profound analysis on postcystectomy radiotherapy.
Summary:
- Local recurrence rates after cystectomy are generally low.
- Adjuvant radiotherapy is analyzed for specific high-risk tumors.
- The study focuses on identifying tumors that benefit from radiotherapy to reduce recurrence.
Impact:
- Provides insights into optimizing radiotherapy use in specific post-cystectomy cancer cases.
- Aims to improve treatment strategies for patients with high local recurrence risk.
- Contributes to a better understanding of adjuvant radiotherapy's role in managing certain cancers.
